NCT03043742View on ClinicalTrials.gov

Stem Cell Heart Injections During Laser Revascularization Surgery for Treatment of Chronic Ischemic Heart Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 12, 2016

Primary Completion Date

November 12, 2020

Study Completion Date

November 12, 2020

Conditions
Chronic Ischemic Heart Disease
Interventions
DRUG

Bone Marrow Derived Autologous CD133+ Selected Cell Product

Injection of bone marrow derived autologous CD133+ cell product into laser channels during Trans-Myocardial Revascularization

Trial Locations (1)

40536

University of Kentucky Healthcare, Lexington

All Listed Sponsors
lead

Michael Sekela

OTHER

NCT03043742 - Stem Cell Heart Injections During Laser Revascularization Surgery for Treatment of Chronic Ischemic Heart Disease | Biotech Hunter | Biotech Hunter